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Memory CD4 T cells are the primary target of 
HIV (Schnittman et al., 1990). Massive deple-
tion of this cell population occurs during pri-
mary infection (Mattapallil et al., 2005), and 
long-term antiretroviral therapy (ART) only 
partially restores the memory CD4 T cell pool 
(Guadalupe et al., 2003; Brenchley et al., 2004). 
HIV-infected activated CD4 T cells escaping 
from HIV-specific cytotoxic CD8 T cells and 
the virus cytopathic effect may enter a quies-
cent state and represent the major source of 
latently HIV-infected cells (Chun et al., 1997a,b) 
and the major obstacle for HIV eradication (Chun 
et al., 1997a,b; Finzi et al., 1997; Wong et al., 
1997). Estimates of the half-life of the HIV latent 
reservoir in blood indicate that as long as 70 years 
might be required for the eradication of the la-
tent reservoir in the presence of fully suppressive 
antiviral therapy (Siliciano et al., 2003). Recent 
studies in blood have identified central memory 
(defined by the CD45RACCR7+CD27+ phe-
notype) and transitional memory (CD45RA 
CCR7CD27+) CD4 T cells as the major cel-
lular compartments of the HIV latent reservoir 
(Chomont et al., 2009). Although it is known that 
HIV replication is dependent on the state of cell 
activation (McDougal et al., 1985; Stevenson 
et al., 1990), it is not clear whether there is a 
memory CD4 T cell compartment predomi-
nantly responsible for active virus replication 
and production.
Lymphoid organs are the primary anatom-
ical compartments for both the generation of 
the immune response (Allen et al., 2007) and 
for HIV replication and spreading (Pantaleo 
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In the present study, we have investigated the distribution of HIV-specific and HIV-infected 
CD4 T cells within different populations of memory CD4 T cells isolated from lymph nodes 
of viremic HIV-infected subjects. Four memory CD4 T cell populations were identified on the 
basis of the expression of CXCR5, PD-1, and Bcl-6: CXCR5PD-1Bcl-6, CXCR5+PD-1Bcl-6, 
CXCR5PD-1+Bcl-6, and CXCR5+PD-1+Bcl-6+. On the basis of Bcl-6 expression and func-
tional properties (IL-21 production and B cell help), the CXCR5+PD-1+Bcl-6+ cell population 
was considered to correspond to the T follicular helper (Tfh) cell population. We show that 
Tfh and CXCR5PD-1+ cell populations are enriched in HIV-specific CD4 T cells, and these 
populations are significantly increased in viremic HIV-infected subjects as compared with 
healthy subjects. The Tfh cell population contained the highest percentage of CD4 T cells 
harboring HIV DNA and was the most efficient in supporting productive infection in vitro. 
Replication competent HIV was also readily isolated from Tfh cells in subjects with nonpro-
gressive infection and low viremia (<1,000 HIV RNA copies). However, only the percentage of 
Tfh cells correlated with the levels of plasma viremia. These results demonstrate that Tfh cells 
serve as the major CD4 T cell compartment for HIV infection, replication, and production.
© 2013 Perreau et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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predominantly restricted to the CXCR5+PD-1+ cell popula-
tion (Fig. 1, A and B). In the representative viremic HIV- 
infected subject shown, Bcl-6, the primary marker of Tfh cells 
(Chtanova et al., 2004; Johnston et al., 2009), was expressed 
in >80% of CXCR5+PD-1+ cells, whereas it was expressed 
in a minor percentage of the other CD4 T cell populations 
(Fig. 1 B) and 97% of CXCR5+PD-1+ cells also expressed 
ICOS (Fig. 1 C). Interestingly, ICOS was also expressed in a 
large proportion (54.9%) of CXCR5PD-1+ CD4 T cells 
(Fig. 1 C). To determine the functional cytokine profile, 
lymph node mononuclear cells were stimulated with PMA 
plus ionomycin and the production of IL-21, IL-2, IFN-, 
and TNF was assessed. The expression of CXCR5 and PD-1 
and the percentage of the four cell populations were not in-
fluenced by the in vitro culture (unpublished data). The rep-
resentative flow cytometry cytokine profile shown in Fig. 1 
(D and E) indicated that IL-21 was predominantly produced 
by CXCR5+PD-1+ cells (45% of cells), followed by the 
CXCR5PD-1+ cell population (30% of cells), whereas 
<5% of the CXCR5+PD-1 and CXCR5PD-1 cell pop-
ulations produced IL-21. Interestingly, the CXCR5+PD-1+ 
cell populations comprised several distinct IL-21+ and IL-21 
cytokine-producing cell populations: IL-21/IL-2/TNF (18%); 
IL-21/IL-2/TNF/IFN- (8%); IL-21/IL-2, IL-21/TNF, and 
single IL-21 (5%); and IL-2/TNF (15%) and single TNF 
(18%; Fig. 1 E). The cytokine profile of IL-21–producing 
CXCR5PD-1+ CD4 T cells was similar to that of CXCR5+ 
PD-1+ cells (Fig. 1 E). The most represented cytokine-pro-
ducing cell populations within CXCR5PD-1- and CXCR5+ 
PD-1 cells were IL-2/TNF, single TNF, and single IL-2 
(Fig. 1 E). Similar results were obtained in HIV-negative sub-
jects (unpublished data). Finally, to determine the ability to 
support Ig production from B cells, the four sorted CD4 T cell 
populations were isolated from three viremic subjects and 
co-cultured with sorted purified GC B cells isolated from the 
same lymph nodes in the presence of Staphylococcus enterotoxin 
B (SEB) for 5 d. Only CXCR5PD1+ and CXCR5+PD1+ 
cell populations supported IgM, IgG1, and IgA production 
from GC B cells (Fig. 1 F). Similar results were obtained with 
memory and naive B cells (unpublished data).
The expression of Bcl-6 together with the production of 
IL-21 and the ability to support Ig production indicate that 
CXCR5+PD-1+ cells likely correspond to Tfh cells and we 
will refer to them as Tfh cells throughout the study. Further-
more, the CXCR5PD-1+Bcl-6 cell population expressed 
ICOS, produced IL-21, and was able to support Ig produc-
tion. A recent study (Wang et al., 2011) in human tonsils 
has shown that CXCR5PD-1+ CD4 T cells are located just 
outside the GC; it cannot be excluded that this PD-1+ CD4 
T cell population may contain precursors of Tfh cells.
Relative frequency of memory lymph node CD4 T cell 
populations in HIV-infected versus healthy subjects
The relative frequency of the four memory CD4 T cell pop-
ulations was then compared in lymph nodes of healthy sub-
jects, viremic chronically HIV-infected subjects, and subjects 
et al., 1991, 1993; Embretson et al., 1993; Brenchley et al., 
2004). A phenotypic and functionally distinct CD4 T cell 
population known as T follicular helper (Tfh) cells resides 
within the germinal centers (GCs). It is specialized in provid-
ing help to B cells and is necessary for GC formation, Ig class 
switch, somatic hypermutation of antibody, and maturation 
of B cells into plasma cells and memory B cells (Breitfeld 
et al., 2000; Schaerli et al., 2000; Kim et al., 2001; Fazilleau 
et al., 2009a,b). The transcription factor Bcl-6 (Chtanova et al., 
2004; Johnston et al., 2009) is the primary marker of Tfh 
cells, whereas other markers, such as CXCR5 (the chemokine 
receptor for CXCL13), inducible T cell co-stimulator (ICOS), 
and PD-1 (Breitfeld et al., 2000; Schaerli et al., 2000; Kim 
et al., 2001; Fazilleau et al., 2009a), are not exclusive of Tfh 
cells. Tfh cells produce a variety of cytokines, including IL-21 
which is critical for promoting B cell maturation (Ozaki 
et al., 2002; Chtanova et al., 2004; Fazilleau et al., 2009a,b; 
Avery et al., 2010).
Recent studies have shown an expansion of Tfh cells in 
HIV and simian immunodeficiency virus (SIV) infection (Hong 
et al., 2012; Lindqvist et al., 2012; Petrovas et al., 2012) and 
that Tfh cells are susceptible to SIV infection (Petrovas et al., 
2012) and are enriched in SIV-infected cells (Brenchley et al., 
2012). However, no data are available on the HIV infection 
of Tfh cells and their role as potential reservoir for HIV.
In the present study, we have investigated memory CD4 
T cell populations isolated from lymph nodes of 23 subjects 
with chronic HIV infection with CD4 T cell count >400 per 
mm3 and plasma HIV RNA levels >5,000 copies per ml, from 
14 subjects with undetectable plasma viremia (<20 HIV RNA 
copies per ml) after 72 wk of ART, from 3 subjects with 
nonprogressive HIV disease, i.e., long-term nonprogressors 
(LTNPs) and low plasma HIV viremia levels, and from 13 
HIV-negative subjects. Lymph nodes from the same patients 
were obtained at baseline (before initiation of therapy) and 
72 wk after ART.
The results presented demonstrate that the memory lymph 
node CD4 T cell population corresponding to Tfh cells, i.e., 
the CXCR5+PD-1+ cell population, and the CXCR5PD-1+ 
cell population were enriched in HIV-specific CD4 T cells, 
and that the Tfh cell population contained the highest per-
centage of HIV-infected cells and was the most efficient in 
supporting virus replication and production.
RESULTS
Characterization of memory CD4 T cell  
populations in lymph nodes
Lymph node mononuclear cells from chronically HIV-infected 
viremic subjects and healthy subjects (unpublished data) were 
stained with CD45RA, CD3, CD4, CD8, CXCR5, PD-1, 
ICOS, and Bcl-6 antibodies. Four populations of CD45RA 
memory CD4 T cells were identified on the basis of the 
expression of PD-1 and CXCR5: CXCR5PD-1, CXCR5+ 
PD-1, CXCR5PD-1+, and CXCR5+PD-1+ (Fig. 1 A). 
The gating strategy used was based on the expression of Bcl-6 
within the four CD4 T cell populations. Bcl-6 expression was 
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Figure 1. Characterization of Tfh cells in lymph nodes. Lymph node mononuclear cells were isolated from viremic HIV-infected subjects (n = 15) and 
stained with anti-CD3, anti-CD4, anti-CD45RA, anti-CXCR5, anti-PD-1, anti-ICOS, and anti–Bcl-6 antibodies. (A) Representative flow cytometry profile of 
lymph node memory (CD45RA) CD4 T cell populations expressing CXCR5 and/or PD-1 in one viremic HIV-infected subject. Density cells in black correspond 
to total CD4 T cells, whereas the blue dots identify Bcl-6+CD4+ T cells. (B and C) Surface expression of Bcl-6 (B) or ICOS (C) in CXCR5PD-1, CXCR5PD-1+, 
CXCR5+PD-1, and CXCR5+PD-1+ memory CD4 T cell populations. (D) CD4 T cells were gated on total IFN-, TNF, IL-2, and IL-21 cytokine-producing cells, and 
IL-21 and IL-2 expression was analyzed. (E) Functional cytokine profile in CXCR5PD-1, CXCR5PD-1+, CXCR5+PD-1, and CXCR5+PD-1+ CD4 T cell popula-
tions from viremic HIV-infected subjects. All the possible combinations of the responses are shown on the x axis, and the percentage of the functionally dis-
tinct cell populations within the responding CD4 T cells are shown on the y axis. Responses are grouped and color-coded on the basis of the combinations of 
the cytokines produced. Spots correspond to the fractions of functionally distinct T cell populations within the total CD4 T cells. The pie charts above summa-
rize the data, and black arcs identify IL-21–producing cell populations (*, P < 0.003). Error bars correspond to mean ± SD. (F) CXCR5PD-1, CXCR5PD-1+, 
CXCR5+PD-1, and CXCR5+PD-1+ CD4 T cell populations were sorted from three viremic HIV-infected subjects. Cells were cultured with autologous GC B cells 
(CD19+CD38+IgD) in the presence of SEB. IgM, IgG1, and IgA production was assessed at day 5 by Luminex. The grade of purity of the sorted cell populations 
was >97% in all experiments. *, P < 0.05. Error bars correspond to mean ± SEM. Statistical significance was obtained using Student’s t test.
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Distribution of HIV-specific CD4 T cells within the memory 
lymph node CD4 T cell populations
We then investigated the distribution of HIV-specific CD4 
T cells within the four cell memory CD4 T cell populations. 
Lymph node mononuclear cells of 11 viremic subjects were 
stimulated with potential T cell epitope (PTE) peptide pools 
(Li et al., 2006) derived from Gag (2 pools), Pol (3 pools), and 
Env (3 pools). It has been previously shown (Betts et al., 2001) 
that CD4 T cell responses specific at Gag, Pol, and Env corre-
spond to 80% of total HIV-specific CD4 T cells. HIV-specific 
CD4 T cells were identified by the ability to produce IL-2, 
IFN-, and TNF. HIV-specific CD4 T cell responses to the two 
Gag and three Pol PTEs peptide pools were detected within 
the four memory (CD45RA) CD4 T cell populations of all 
the 11 subjects, whereas Env-specific responses were detected 
in six out of nine subjects and responses against the three Env 
pools in three out of six subjects (Fig. 3, A and C). Of note, 
HIV-specific CD4 T cells were not detected in the naive 
(CD45RA+) CD4 T cell population (Fig. 3, B and C). Inter-
estingly, the Tfh cell population was the mostly enriched in 
Gag-, Pol-, and Env-specific CD4 T cells (Fig. 3, A and C). 
Tfh (9.49 ± 2.64%) and CXCR5PD-1+ (6.32 ± 1.69%) cell 
populations were also significantly (P < 0.05) enriched in the 
total HIV-specific CD4 T cells as compared with CXCR5+ 
PD-1 (3.69 ± 0.69%) and CXCR5PD-1 (0.76 ± 0.21%) 
cell populations (Fig. 3 D). With regard to the cytokine pro-
file, CXCR5PD-1 and CXCR5+PD-1 cells were enriched 
in single TNF-producing cells and CXCR5PD-1+ cells in 
treated for 72 wk with ART. No or minor differences were 
observed in the frequencies of CXCR5PD1 (P > 0.05) 
and CXCR5+PD1 (P = 0.0406) cell populations between 
the three study groups (Fig. 2, A and B). Interestingly, 
CXCR5PD-1+ and Tfh cell populations were significantly 
increased during the viremic phase of HIV infection, i.e., 
5.1% (P < 0.0001) and 3.8% (P = 0.0046) as compared with 
healthy subjects where the percentage of each cell population 
was 0.9%. In addition, both cell populations were significantly 
decreased after ART, i.e., CXCR5PD-1+ to 3.3% (P = 
0.0078) and Tfh cells to 1.3% (P = 0.0045; Fig. 2, A and B). 
With regard to the cytokine profile, the frequency of IL-21–
producing cells was significantly increased (P < 0.05) within 
the CXCR5PD-1+, Tfh, and, to a lower extent, within 
CXCR5+PD-1 cell populations from viremic HIV-infected 
subjects as compared with healthy subjects (Fig. 2 C). No differ-
ences in the frequency of TNF, IFN-, and IL-2–producing 
Tfh cells were observed between viremic HIV-infected subjects 
and healthy subjects (unpublished data), whereas these cytokines 
were significantly reduced within the other CD4 T cell pop-
ulations of viremic HIV-infected subjects (unpublished data).
Therefore, these results demonstrate that Tfh and 
CXCR5PD-1+ cell populations are not depleted but in-
creased during the viremic phase of HIV infection. In support 
of these results, recent studies in nonhuman primates (Hong 
et al., 2012; Petrovas et al., 2012) and in HIV-infected subjects 
(Lindqvist et al., 2012) have shown that Tfh cells were also 
expanded in lymph node tissues.
Figure 2. Frequencies of Tfh cells in 
lymph nodes. (A) Representative flow cytom-
etry profiles of CXCR5 and/or PD-1 expression 
in CD4 T cell populations from an HIV-nega-
tive subject (control) and from one HIV-
infected subject before (week 0) and after ART 
(week 72). (B) Frequencies of CXCR5PD-1, 
CXCR5PD-1+, CXCR5+PD-1, and Tfh CD4  
T cell populations in HIV-negative subjects (HS; 
n = 12) and chronically HIV-1–infected sub-
jects (n = 13) at weeks 0 (BSL) and 72 (W72). 
(C) Frequencies of IL-21–producing cells in 
HIV-negative (n = 13; open circles) and vire-
mic HIV-infected (n = 15; closed squares) 
subjects. Cells were stimulated with PMA plus 
ionomycin for 6 h, permeabilized, and stained 
with anti-CD3, anti-CD4, anti–IL-21, anti–IFN-, 
anti-TNF, and anti–IL-2 antibodies. *, P < 0.05; 
***, P < 0.0001. Error bars correspond to mean ± 
SEM. Statistical significance was obtained 
using one-way ANOVA (Kruskal-Wallis test) 
followed by Student’s t test.
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of virus replication by ART (week 72) within the four CD4 
T cell populations (Fig. 3 E), whereas no major changes were 
observed in the cytokine profile (not depicted). No cytokine 
production was detected after stimulation with HIV PTE pep-
tide pools of lymph node mononuclear cells from HIV-negative 
single IFN-–producing cells as compared with Tfh cells 
(unpublished data). IL-21 was barely detected after antigen 
(Ag)-specific stimulation but consistently produced after PMA/
ionomycin stimulation (unpublished data). Of note, HIV-specific 
CD4 T cell frequencies significantly decreased after suppression 
Figure 3. Flow cytometry profiles of HIV-specific lymph node CD4 T cell populations. Lymph node mononuclear cells were isolated from viremic 
HIV-infected subjects before (week 0; n = 11) or after (week 72; n = 5) ART therapy and were stimulated or not with HIV peptide pools (Gag, Pol, and Env), 
and then permeabilized and stained with anti-CD3, anti-CD4, anti-CD45RA, anti–PD-1, anti-CXCR5, anti–IL-21, anti–IFN-, anti-TNF, and anti–IL-2 anti-
bodies. (A and B) Representative flow cytometric cytokine profiles of Gag peptide pool #1 (Gag #1) and Gag #2–specific CD4 T cell populations producing 
IL-2 and/or TNF from one viremic HIV-positive subject in the memory (A) and naive T cell populations (B). (C and D) Percentage of Gag-, Pol-, and Env-
specific (C) and of HIV-specific (Gag+Pol+Env; D) T cells among total CD3+CD4+ T cells making any cytokine (IFN-, TNF, IL-2, or IL-21) in viremic HIV-
infected subjects before ART therapy (n = 11). Error bars correspond to mean ± SEM. (E) Changes in the frequencies of the HIV-specific memory CD4  
T cells producing anyone cytokine in viremic HIV-infected subjects before (week 0; BSL) and after (week 72; W72) ART therapy (n = 5). *, P < 0.05; **, P < 
0.001; ***, P < 0.0001. Statistical significance was obtained using Student’s t test.
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Figure 4. Frequencies of B cell populations in lymph nodes of HIV-negative and viremic untreated and treated HIV-infected subjects. Lymph 
node mononuclear cells were isolated from HIV-negative subjects (n = 12, control) and from HIV-infected subjects (n = 11) at weeks 0 and 72 and were 
stained with anti-CD19, anti-CD27, anti-CD38, and anti-IgD antibodies. (A) Representative flow cytometry profile of naive and non-naive B cells based  
on the expression of CD19+, CD27, and IgD+. Graphs show cumulative percentages of naive and non-naive B cell populations in HIV-negative subjects 
(HS; n = 12) and HIV-positive subjects (n = 11) at weeks 0 (BSL) and 72 (W72). (B) Representative flow cytometry profile of non-naive B cell populations 
based on the expression of CD19, IgD, and CD38. Naive B cells (CD19+IgD+CD27) were excluded. Plots show unswitched memory (CD19+IgD+), switched 
memory (CD19+IgDCD38), GC (CD19+IgDCD38+), and plasma cell (CD19+IgDCD38high) B cell populations in one HIV-negative subject (control) and 
one HIV-positive subject at weeks 0 and 72. Graphs show cumulative data of the different memory B cell populations of HIV-negative subjects (n = 12) 
and of HIV-positive subjects (HS, n = 11) at weeks 0 (BSL) and 72 (W72). (C) Correlation between the percentage of Tfh cells and GC B cells in HIV-negative 
subjects (n = 12; open circles) and HIV-infected subjects before (chronic untreated; n = 14; gray squares) and after ART therapy (chronic treated; n = 11; 
black squares). (D) Correlation between the percentage of CXCR5PD-1, CXCR5PD-1+, CXCR5+PD-1, or Tfh cells and plasma viremia in viremic chroni-
cally HIV-infected subjects (n = 23). *, P < 0.05; **, P < 0.001; ***, P < 0.0001. Error bars correspond to mean ± SD. P-values were derived from Student’s  
t test for multiple comparisons (B), or a Spearman rank test for correlations (C and D).
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subjects (unpublished data). These further strengthen previous 
observations (Lindqvist et al., 2012) indicating enrichment of 
HIV-specific CD4 T cells within the Tfh cell population.
Relationship between Tfh cells and B cell populations
We next investigated the relationship between Tfh cells and 
different B cell populations. Phenotypic analysis of memory 
B cells is very complex, particularly with regard to the hetero-
geneity of the memory B cell compartment (Sanz et al., 2008). 
Here we have used four major markers, CD19, CD27, CD38, 
and IgD, to define different B cell populations (Sanz et al., 
2008). On the basis of these markers, CD19+IgD+CD27 
cells correspond to naive B cells and the non-naive B cells cor-
respond to a mixed B cell population including memory, GC, 
and plasma cells. Of note, CD27 memory B cells are present 
at low percentage (5%) in healthy subjects and may expand in 
different pathological conditions (Ehrhardt et al., 2005; Wirths 
and Lanzavecchia, 2005; Wei et al., 2007). Four populations 
of non-naive B cells were identified by excluding naive B cells 
based on the expression of CD38 and IgD: unswitched mem-
ory (CD19+IgD+); switched memory (CD19+IgDCD38); 
GC (CD19+IgDCD38+) B cells; and plasma cells (CD19+IgD 
B cells CD38high; Fig. 4 A). Naive (CD19+IgD+CD27 B cells), 
unswitched memory, and switched memory B cell popula-
tions were significantly reduced (naive: P = 0.0153; unswitched: 
P = 0.0003; switched: P < 0.0001), whereas GC B cells and 
plasma cells significantly expanded (six- and sevenfold increase, 
respectively) in viremic HIV-infected subjects as compared 
with healthy subjects (P < 0.0001; Fig. 4, A and B). Suppres-
sion of virus replication by ART was associated with an in-
crease of both naive (not significant) and memory B cell 
populations (P < 0.04) and a significant reduction of GC B cells 
and plasma cells (P < 0.0001; Fig. 4, A and B). The percent-
age of Tfh cells positively correlated with the percentage of 
GC B cells in healthy subjects (R = 0.6643, P = 0.0185), in 
viremic subjects (R = 0.7802, P = 0.001), and in ART-treated 
subjects (R = 0.8273, P = 0.0017; Fig. 4 C). Interestingly, only 
the percentage of Tfh cells was significantly correlated with 
the levels of plasma viremia (R = 0.6035, P = 0.0023; Fig. 4 D). 
Therefore, consistent with previous studies (Lindqvist et al., 
2012; Petrovas et al., 2012), these results further support the 
hypothesis that the quantitative changes in Tfh cells and dif-
ferent B cell populations are driven by HIV. In addition, our 
results have shown a strong correlation between the proportion 
of Tfh cells and plasma viremia levels, thus indicating a relation-
ship between Tfh cells and HIV replication and production.
Distribution of HIV-infected cells within memory  
lymph node CD4 T cell populations
Previous studies have shown that HIV-specific CD4 T cells 
are preferentially infected by HIV (Douek et al., 2002). Our 
finding that Tfh cells are enriched in HIV-specific cells, to-
gether with the correlation of their percentage with the levels 
of plasma viremia, suggested that Tfh cells may contain higher 
numbers of HIV-infected cells and be more efficient in sup-
porting virus replication. To test this hypothesis, the four 
CD4 T cell populations were sorted on the basis of the ex-
pression of CXCR5 and PD-1 from 21 viremic HIV-infected 
subjects and assessed for total HIV DNA. The highest num-
ber of HIV DNA copies was found in Tfh cells, i.e., mean 
50,953 copies/106 mononuclear cells, thus indicating that 
5.1% of Tfh cells were infected with HIV assuming one 
HIV DNA copy/per infected cell (Fig. 5 A). The CXCR5 
PD-1+ cell population contained a mean 23,182 HIV DNA 
copies/106 cells (2.3% infected cells; Fig. 5 A), the CXCR5+ 
PD-1 11,833 HIV DNA copies/106 cells (1.1% infected 
cells), and the CXCR5PD-1 cell population 8,191 HIV 
DNA copies/106 cells (0.8% infected cells; Fig. 5 A). The dif-
ferences in viral load between Tfh and the other cell populations 
were significant (P < 0.05). These results are in agreement 
with a recent study in SIV infection (Brenchley et al., 2012). 
Of note, a higher frequency of HIV infection in blood PD-1+ 
memory CD4 T cells has been reported in a recent study 
(Chomont et al., 2009). A significant reduction (1.5–2.0 logs, 
P < 0.05) in the frequency of cells harboring HIV DNA was 
consistently observed 72 wk after ART (Fig. 5 B). However, 
HIV DNA was detected in all the four cell populations, thus 
indicating that may serve as cellular compartments for the 
HIV latent reservoir.
HIV replication and production within memory  
lymph node CD4 T cell populations
We next explored the efficiency of the four CD4 T cell popu-
lations to support active virus replication and production. We 
used two strategies: (1) isolation of replication competent 
virus from five subjects with high viremia (>15,000 HIV RNA 
copies/ml of plasma), from three LTNP with viremia ranging 
between 200 and 1,000 HIV RNA copies, from one subject 
experiencing a transient virus blip (1,800 HIV RNA copies), 
and from three ART-treated subjects with viremia <5 HIV 
RNA copies; and (2) HIV infection in vitro. For the first 
strategy, sorted purified CD4 T cell populations were isolated, 
stimulated with anti-CD3 plus anti-CD28 antibodies, and the 
production of HIV p24 was determined at days 0, 2, and 5 in 
the subjects with high viremia. Evidence for rapid HIV repli-
cation and significantly higher levels of HIV p24 were mea-
sured in the Tfh cell cultures already at day 2 as compared 
with those measured in the other cell populations (P < 0.05). 
CXCR5PD-1+ cells also efficiently supported HIV replica-
tion, whereas CXCR5+PD-1 and CXCR5PD-1 cell pop-
ulations were poorly efficient (Fig. 5 C). The differences between 
Tfh and the other CD4 cell populations were more striking 
in the three LTNP and in the subject with transient virus blip 
(viremia was undetectable at week 84; Fig. 5 D). HIV p24 
production was significantly higher in Tfh as compared with 
the other cell population at day 3 (Fig. 5 D). The differences 
were not significant between Tfh and CXCR5PD-1+ cells at 
day 7, although the levels of p24 in the two LTNP with a few 
100 HIV RNA copies substantially higher in the Tfh cell cul-
tures (Fig. 5 D). HIV p24 was rarely or not detected in CXCR5+ 
PD-1 and CXCR5PD-1 cells cell cultures (Fig. 5 D). 
HIV p24 production was not detected in the cell cultures of 
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p24 production that may be caused at later time points by dif-
ferences in proliferation capacity between the four CD4 T cell 
populations. HIV p24 production was significantly higher in 
Tfh cells as compared with the other CD4 T cell populations 
at day 3 after infection (Fig. 5 E). Therefore, these results indi-
cate that Tfh cells contain a higher number of HIV-infected 
cells during the viremic phase and are the major CD4 T cell 
compartment for active HIV replication and production.
State of activation and proliferation capacity  
of memory lymph node CD4 T cell populations
HIV integration and replication is dependent on the state of 
activation of the target cells (McDougal et al., 1985; Stevenson 
long-term-treated subjects with viremia <20 HIV RNA cop-
ies (unpublished data). The failure in the virus isolation in the 
long-term-treated subjects is likely the result of the very low 
frequency of HIV-infected CD4 T cells harboring replication-
competent virus, which may be in the range of one per million 
CD4 T cells in the latent pool of blood memory CD4 T cells 
(Chun et al., 1997a) and the very small number (5 × 104–105) 
of Tfh cells used in the current virus isolation experiments.
With regard to the second strategy, sorted purified CD4 
T cell populations were isolated from lymph nodes of three 
HIV-negative subjects, inoculated with HIV, and stimulated with 
anti-CD3 plus anti-CD28 antibodies. HIV p24 production 
efficiency was measured at day 3 to minimize differences in 
Figure 5. HIV DNA load and HIV production in lymph node CD4 T cell populations. (A) HIV DNA load in sorted CXCR5PD-1, CXCR5PD-1+, 
CXCR5+PD-1, and CXCR5+PD-1+ memory (CD45RA) CD4 T cell populations from viremic HIV-infected subjects (n = 21). (B) HIV DNA load before (week 0; 
BSL) and after (week 72; W72) ART therapy in three HIV-infected subjects. (C) CXCR5PD-1, CXCR5PD-1+, CXCR5+PD-1, and CXCR5+PD-1+ memory 
CD4 T cell populations were sorted from HIV-infected subjects with viremia >15,000 HIV RNA copies/ml (n = 5), and HIV replication was assessed at days 0, 
2, and 5 after anti-CD3 plus anti-CD28 stimulation by measuring p24 production using an electrochemiluminescence assay. (D) CXCR5PD-1, CXCR5PD-1+, 
CXCR5+PD-1, and CXCR5+PD-1+ memory CD4 T cell populations were sorted from four HIV-infected subjects (n = 4) with low viremia (<2,000 HIV RNA 
copies/ml) and cultured with heterologous CD8-depleted blood mononuclear cells. HIV production was assessed at days 0, 3, and 7 after anti-CD3 plus anti-
CD28 stimulation. The different symbols represent individual subjects. (E) Productive HIV infection in sorted CXCR5PD-1, CXCR5PD-1+, CXCR5+PD-1, 
and CXCR5+PD-1+ memory CD4 T cell populations of healthy subjects (n = 3) 3 d after anti-CD3 plus anti-CD28 stimulation. *, P < 0.05; **, P < 0.001. Error 
bars correspond to mean ± SEM. P-values were obtained using one-way ANOVA (Kruskal-Wallis test) followed by Student’s t test.
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Because PD-1, which was coexpressed with Ki-67, may 
define cells with reduced proliferation capacity (Day et al., 
2006; Trautmann et al., 2006), the four sorted purified mem-
ory CD4 T cell populations were stimulated with anti-CD3 
plus anti-CD28 antibodies and cell proliferation was deter-
mined using the CFSE flow cytometry–based assay (Fig. 6 D). 
A significantly (P < 0.01) larger proportion (60%) of CFSE-
low CXCR5PD-1 and CXCR5+PD-1 cells was detected 
at day 5 of culture as compared with 10–15% of CFSE-low 
CXCR5PD-1+ and Tfh cells, thus indicating that the PD-1+ 
T cell populations have limited proliferation capacity. These 
results are consistent with recent studies analyzing Ki-67 and 
cell cycling capacity in Tfh cells (Petrovas et al., 2012) or 
Ki-67 expression and proliferation capacity in Tfh cells (Rasheed 
et al., 2006) and in different PD-1+ CD4 T cell populations 
isolated from human tonsils (Wang et al., 2011).
et al., 1990). We therefore investigated the relationship be-
tween the state of activation of the four cell populations and 
viral load content and the ability to support productive HIV 
infection. The four cell populations were analyzed for the 
expression of Ki-67, which defines cycling cells (Gerdes 
et al., 1984) and is also an indirect measure of the state of 
cell activation. Interestingly, Ki-67 was significantly more 
expressed in Tfh (18%) and CXCR5PD-1+ (18%) cells as 
compared with CXCR5PD-1 and CXCR5+PD-1 (P < 
0.0008; Fig. 6 A). The percentage of Ki-67 cells correlated 
with total HIV DNA (R = 0.6753, P < 0.0001) and with 
the ability to support HIV replication (R = 0.6735, P = 
0.004; Fig. 6, B and C). The expression of Ki-67 within the 
same CD4 T cell populations was 50% lower in lymph 
node CD4 T cell populations of five HIV-negative subjects 
(unpublished data).
Figure 6. Ki-67 expression and cell proliferation in lymph node CD4 T cells. Lymph node mononuclear cells isolated from viremic chronically HIV-1–
infected subjects (n = 10) were permeabilized and stained with anti-CD3, anti-CD4, anti-CD45RA, and anti–Ki-67 antibodies. (A) Representative flow cytom-
etry profiles showing Ki-67 expression in CD4 T cell populations. Graph shows data from 10 viremic HIV-infected subjects. (B) Correlation between Ki-67 
expression and HIV-1 DNA copies/106 cells (n = 9). (C) Correlation between Ki-67 expression and p24 production (n = 4). (D) Representative flow cytometry 
profile showing proliferating (CFSE low) CXCR5PD-1, CXCR5PD-1+, CXCR5+PD-1, and CXCR5+PD-1+ CD4 T cell populations. Sorted memory (CD45RA) 
CD4 T cell populations from viremic HIV-infected subjects (n = 5) were labeled with CFSE and stimulated with anti-CD3 plus anti-CD28 antibodies for 5 d and 
acquired on an LSR SORP (BD). Flow cytometry profiles of unstimulated cells (negative control) are also shown. *, P < 0.05; ***, P < 0.0001. Error bars corre-
spond to mean ± SEM. P-values were obtained using Student’s t test for multiple comparisons (A and D), or a Spearman rank test for correlations (B and C).
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that the relative percentage of Tfh cells was significantly in-
creased in viremic subjects and decreased after suppression of 
viremia by ART, strongly suggested that Tfh cells repre-
sented an important cellular compartment for HIV infection. 
In this regard, we have performed a comprehensive investi-
gation to determine the role and the importance of Tfh and 
the other CD4 T cell populations as cellular compartments 
for HIV infection, replication, and production. These issues 
have not been previously investigated.
Previous studies have shown that HIV-specific cells were 
enriched in HIV-infected cells (Douek et al., 2002). We 
demonstrate that Tfh cells contained the higher proportion of 
CD4 T cells harboring HIV DNA. Our results are in agree-
ment with a recent study in SIV infection (Brenchley et al., 
2012). Furthermore, Hufert et al. (1997) showed before the 
discovery of Tfh cells that CD4 T cells residing within GCs 
and expressing CD57, which is expressed by a subset of Tfh 
cells, were preferentially infected by HIV. Our finding, al-
though important, was not sufficient to delineate the role of 
Tfh in HIV infection. We therefore assessed the ability of Tfh 
cells to support HIV replication and production after HIV 
inoculation of different memory CD4 T cell populations 
in vitro and isolation of replication competent HIV from the 
different memory CD4 T cell populations. Tfh cells were 
clearly the most efficient in supporting both HIV replication 
and production under the above experimental conditions. In 
this regard, it should be underscored that the differences be-
tween Tfh cells and the other memory CD4 T cell popula-
tions were even more striking when replication competent 
HIV was isolated from patients with low viremia levels, such 
as LTNP, and from one patient experiencing a transient viral 
blip. Limit dilution experiments of the different cell popula-
tions would have been instrumental to quantify more pre-
cisely the differences in virus replication and production 
between the different memory CD4 T cell populations. 
However, these experiments are not feasible, particularly for 
Tfh and CXCR5PD-1+ cell populations as a result of the 
limited total number of cells (range 30 to 100 million mono-
nuclear cells) per lymph node, which prevents purification of 
large cell numbers from these minority cell populations. Of 
note, we have also shown that the memory CXCR5PD-1+ 
CD4 T cell population was also enriched in HIV-specific 
CD4 T cells and second only to Tfh cells for HIV DNA load 
and ability to support virus replication and production. Col-
lectively, the results presented here provide evidence that Tfh 
cells serve as the major CD4 T cell compartment for HIV 
infection, replication, and production.
The state of activation of Tfh and CXCR5PD-1+ cells 
is consistent with the expression of PD-1 and their localiza-
tion in anatomical sites of high levels of cell activation such as 
GCs. The likely enrichment of Ag-specific CD4 T cells (HIV 
and non-HIV specific) within the Tfh cell population and the 
state of activation of Tfh cells may render Tfh cells more sus-
ceptible to infection with HIV. Finally, the localization of 
HIV-specific Tfh in GCs and their exposure to the high vi-
rion load associated with follicular dendritic cells (Embretson 
DISCUSSION
We have investigated the distribution of HIV-specific and 
HIV-infected cells within different memory CD4 T cell pop-
ulations isolated from lymph nodes in three study groups: 
(1) subjects with chronic infection and plasma viremia >5,000 
HIV RNA copies; (2) ART-treated subjects with viremia 
<20 HIV RNA copies; and (3) LTNPs with plasma viremia 
in the range of a few 100 to 1,000 HIV RNA copies. The 
primary findings indicate that the memory lymph node CD4 
T cell population corresponding to Tfh cells was: enriched in 
HIV-specific CD4 T cells; enriched in HIV-infected cells, 
i.e., harboring HIV DNA; and the most efficient in support-
ing virus replication and production.
Several studies (Schaerli et al., 2000; Breitfeld et al., 2000; 
Kim et al., 2001; Chtanova et al., 2004; Fazilleau et al., 2009a; 
Johnston et al., 2009; Ma et al., 2009; Bentebibel et al., 2011; 
Kroenke et al., 2012) using a panel of markers, including 
CXCR5, PD-1, ICOS, and Bcl-6—the latter being the lin-
eage marker of Tfh cells—as well as the levels of expression 
of markers such as CXCR5 and PD-1, have been instrumen-
tal in distinguishing between Tfh cells and other populations 
of memory CD4 T cells. In the present study, Bcl-6 expres-
sion has been the strategy to identify Tfh cells, and the results 
obtained indicated that Bcl-6 expression was predominantly 
restricted to the lymph node CD4 T cell population express-
ing higher CXCR5 levels, PD-1, and ICOS. This CD4 
T cell population also produced IL-21 and supported Ig pro-
duction from B cells both functions typical of Tfh cells. In-
terestingly, the memory CD4 T cell population defined by 
the CXCR5PD-1+Bcl-6 phenotype partially (50%) ex-
pressed ICOS and was also able to produce IL-21 and to sup-
port Ig production from B cells. These results are consistent 
with the previous study showing that the CXCR5PD-1+ 
CD4 T cell population is located outside the GC (Wang 
et al., 2011) and that it may contain precursors of Tfh cells.
The relative percentage of Tfh cells and CXCR5PD-1+ 
CD4 T cell populations significantly increased during the 
viremic phase of infection and decreased after suppression of 
viremia by ART. Consistent with this, the relative percent-
age of GC B cells and plasma cells was similarly modulated by 
the different levels of viremia. These results were obtained in 
a longitudinal study within the same patients. Our observa-
tions are consistent with previous studies performed in SIV 
infection (Hong et al., 2012; Petrovas et al., 2012) or cross-
sectional studies in HIV infection (Lindqvist et al., 2012). 
These results indicated that the changes in the relative per-
centage of both the memory CD4 T cell and B cell popula-
tions were likely driven by HIV.
We show that both the Tfh and the CXCR5PD-1+ 
CD4 T cell populations were enriched in HIV-specific CD4 
T cells. A recent study (Lindqvist et al., 2012) has also shown 
enrichment of HIV-specific CD4 T cells within the Tfh cell 
population. The localization of these cell populations in the 
GCs or just outside is consistent with the critical role that 
HIV-specific Tfh cells play the generation of the HIV anti-
body response. This finding, together with the observations 
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The development of immunological intervention strate-
gies aimed toward a functional HIV cure, i.e., virus control in 
the absence of antiviral therapy, and ultimate HIV eradication 
has recently been the object of extensive debate in the scien-
tific community. Among these immunological interventions, 
anti–PD-1 antibodies represent an attractive strategy because 
this treatment may both reactivate HIV replication in latently 
infected CD4 T cells, causing their death via HIV-mediated 
apoptosis, and rescue the function of HIV-specific CD8 T cells, 
thus leading to killing of infected CD4 T cells. Recent stud-
ies in nonhuman primates have shown partial control of viral 
load after anti–PD-1 treatment (Finnefrock et al., 2009; Velu 
et al., 2009). The identification of Tfh (and, to a lower extent, 
PD-1+CXCR5) cells as the major CD4 T cell compartment 
for HIV replication and production may help to design more 
selective strategies to tackle the cells that are either responsi-
ble for residual virus replication or that support high levels 
of virus replication and production. Development of bi- 
specific antibodies to CD4 and PD-1 coupled to toxins may 
represent an effective strategy to purge HIV-infected Tfh and 
CXCR5PD-1+ cells.
MATERIALS AND METHODS
Study groups and isolation of mononuclear cells. Lymph node biop-
sies were performed in HIV-infected subjects with CD4 T cell counts >400 
cells/mm3 and plasma viremia >5,000 HIV RNA copies/ml enrolled in two 
therapeutic studies evaluating different antiviral drugs combinations. 26 sub-
jects were investigated in the present study. Lymph node biopsies were per-
formed at week 0 before the initiation of therapy and week 72 after therapy. 
Lymph node biopsies were also obtained from three LTNP. The criteria for 
defining nonprogressive disease included: documented HIV infection for 
>8 yr, CD4 T cell counts >500 per µl, and plasma viremia <5,000 HIV 
RNA copies/ml. With regard to HIV-negative subjects, lymph node biop-
sies (inguinal lymph nodes) were performed in 13 subjects who underwent 
vascular (varicose vein stripping) and general (uncomplicated bilateral ingui-
nal herniorrhaphy) surgery. These studies were approved by the Institutional 
Review Board of the Centre Hospitalier Universitaire Vaudois, and all sub-
jects gave written informed consent.
Isolation of lymph node mononuclear cells. Lymph node mononuclear 
cells were isolated by mechanical disruption as previously described (Pantaleo 
et al., 1991) and cells were cryopreserved in liquid nitrogen.
Antibodies. The following antibodies were used: PerCP-Cy5.5–conjugated 
anti-CD278 (ICOS; clone C398.4A), PerCP-Cy5.5–conjugated anti–IL-2 
(clone MQ1-17H12), PE-conjugated anti–IL-21 (clone 3A3-N2), and 
PE-conjugated anti–Ki-67 (clone Ki-67; BioLegend); PeCy7-conjugated 
anti-CD279 (PD-1; clone EH12.1), Alexa Fluor 647– or Alexa Fluor 
488–conjugated anti-CXCR5 (clone RF8B2), APC-H7–conjugated anti-CD3 
(clone SK7), PerCP-Cy5.5–conjugated anti-CD8 (clone SK1), PB-, APC-, 
or PE-CF594–conjugated anti-CD4 (clone RPA-T4), APC-conjugated 
anti-TNF (clone MabII), Alexa Fluor 700–conjugated anti–IFN- (clone 
B27), PE-conjugated anti-IgD (clone IA6-2), Alexa Fluor 488–conjugated 
anti–Bcl-6 (clone K112-91), and PeCy5-conjugated anti-CD45RA (clone 
HI100; BD); PE-conjugated anti-CXCR5 (clone 51505.111; R&D 
Systems); EFluor 625NC-conjugated anti-CD8 (clone RPA-T8) and 
PeCy7-conjugated anti-CD27 (clone O323; eBioscience); ECD-conjugated 
anti-CD45RA (clone 2H4) and ECD-conjugated anti-CD4 (clone T4; 
Beckman Coulter); APC–Alexa Fluor 750–conjugated anti-CD19 (clone 
SJ25-C1) and PE–Texas red–conjugated anti-CD38 (clone HIT2; 
Life Technologies).
et al., 1993; Pantaleo et al., 1993) may warrant infection of 
Tfh cells. These are all factors that may explain why Tfh cells 
represent the major CD4 T cell compartment for HIV infec-
tion, virus replication, and production. Because Tfh cells are 
resident with GCs, an important issue to address is why they 
are not eliminated by HIV-specific CD8 T cells. In this 
regard, CD8 T cells have generally limited access into GCs 
(Connick et al., 2007; King and Sprent, 2012), and it has 
been shown that the CD8 T cells entering GCs have limited 
cytotoxic capacity (Quigley et al., 2007). These are all poten-
tial factors contributing to create a unique microenvironment 
for HIV persistence within GCs. The limited proliferation of 
Tfh and CXCR5PD-1+ cells supports the hypothesis that 
the expression of PD-1 in Tfh cells dissociates TCR signaling 
from proliferation (Kroenke et al., 2012) and also indicates 
that the state of activation associated with PD-1 expression 
in Tfh and CXCR5PD-1+ cells is sufficient for supporting 
HIV replication but not cell proliferation.
The existence of an HIV latent cellular reservoir com-
posed of long-lived resting memory CD4 T cells or the exis-
tence of residual virus replication that replenishes the HIV 
latent cell reservoir are the two main hypotheses proposed to 
explain HIV persistence after suppression of HIV replication 
by ART (Chun et al., 1997a,b; Finzi et al., 1997; Wong et al., 
1997; Siliciano et al., 2003; Chomont et al., 2009). Residual 
HIV replication is supported by studies showing that low 
level plasma viremia, i.e., <20 HIV RNA copies/ml, can be 
measured using more sensitive assays in a large number of 
subjects (Dornadula et al., 1999; Palmer et al., 2003). The 
cells responsible for residual virus replication during ART 
have not yet been identified. Our results suggest that Tfh cells 
can be good candidates for supporting residual virus replica-
tion and eventually for the origin of viral blips (Di Mascio 
et al., 2003). We speculate that any time an infection occurs 
in an ART-treated HIV-infected subject, activation will occur 
in GCs within secondary lymphoid organs, such as lymph nodes 
and gut-associated lymphoid tissues, to generate the immune 
response against the encountered pathogen. Because of their 
fundamental role in the generation of the antibody response, 
Tfh cells will be stimulated, and either preexisting Tfh- 
infected cells shift to an activation state supporting higher 
levels of HIV replication or HIV spreading occurs in the de 
novo generated Tfh cells. This sudden boost in HIV replica-
tion remains a limited entity, i.e., viral blips in the range of a 
few 100 HIV RNA copies (Di Mascio et al., 2003), because 
antiviral therapy prevents efficient spreading of HIV. By sup-
porting residual virus replication and viral blips, Tfh cells 
contribute to the replenishment of the latent reservoir. 
This possibility is also suggested by a recent study (Lüthje 
et al., 2012) demonstrating that Tfh cells can give rise 
to other populations of conventional memory CD4 T cells 
after the end of GC response. Other HIV cellular reservoirs, 
such as macrophages and dendritic cells (Stevenson, 2003), 
have not been investigated here and, together with Tfh cells, 
may represent additional candidates for supporting residual 
virus replication.
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2 × 105 cells) were labeled with CFSE at 37°C for 7min (Life Technologies) 
and cultured for 5 d at 37°C and 5% CO2 in 96-well U-bottom plates coated 
or not with 50 µg/ml anti-CD3 (BD) and 5 µg/ml anti-CD28 (BD) in com-
plete RPMI. The proliferation of the four CD4 T cell populations was as-
sessed by quantifying the percentage of CFSE low cells on a LSR SORP cell 
analyzer (BD).
Assessment of p24 production of CD4 T cell populations from 
HIV-infected subject with high HIV viremia (viremia >15,000 HIV 
RNA copies/ml; n = 5). Sorted CD4 T cell populations (CXCR5PD-1, 
CXCR5PD-1+, CXCR5+PD-1, and CXCR5+PD-1+ CD4 T cells; >5 × 
104 cells) were stimulated for 2 d at 37°C and 5% CO2 in 96-well U-bottom 
plates coated with 50 µg/ml anti-CD3 (BD) and 5 µg/ml anti-CD28 (BD) 
in complete RPMI. Supernatants were collected at days 0, 2, and 5 and ana-
lyzed for the presence of p24 Ag by electrochemiluminescence (ECL; HIVAg; 
Eleciys and Cobas e analyzers; Roche).
Assessment of p24 production of CD4 T cell populations from 
HIV-infected subjects with low HIV viremia (viremia <2,000 HIV 
RNA copies/ml; n = 7). Sorted CD4 T cell populations (CXCR5PD-1, 
CXCR5PD-1+, CXCR5+PD-1, and CXCR5+PD-1+ CD4 T cells; >5 × 
104 cells) were stimulated for 2 d at 37°C and 5% CO2 in 96-well U-bottom 
plates coated with 50 µg/ml anti-CD3 (BD) and 5 µg/ml anti-CD28 (BD) 
and cultured with allogeneic CD8-depleted blood mononuclear cells 
(Miltenyi Biotec) of HIV-uninfected subjects (1:1 ratio) in complete RPMI 
containing 50 U/ml IL-2. Supernatants were collected at days 0, 3, and 7 
and analyzed for the presence of p24 Ag by ECL.
Assessment of HIV infectivity of CD4 T cell populations of HIV 
uninfected subjects. Sorted CD4 T cell populations (>5 × 104 cells) were 
exposed to 300 pg HIVLAV virus for 3 h at 37°C and 5% CO2 and extensively 
washed. Cells were then stimulated for 2 d at 37°C and 5% CO2 in 96-well 
U-bottom plates coated with 50 µg/ml anti-CD3 (BD) and 5 µg/ml anti-
CD28 (BD) and cultured in complete RPMI containing 50 U/ml IL-2. 
Supernatants were collected at day 3 and analyzed for the presence of p24 
Ag by ECL.
HIV DNA quantification. DNA from sorted CD4 T cell populations 
(CXCR5PD-1, CXCR5PD-1+, CXCR5+PD-1, and CXCR5+PD-1+ 
CD4 T cells; 105 cells) was purified using QIAmpDNA Micro kit (QIA-
GEN). HIV-1 DNA levels were determined by a TaqMan real-time PCR 
assay targeting HIV-1 gag gene using the StepOnePlus Real-Time PCR Sys-
tem (Applied Biosystems). qPCR was performed in a final volume of 25 µl 
using 5 µl of DNA, 2.5 µl of 10× PCR buffer (Invitrogen), 1.75 µl of 50 mM 
MgCl2 (Invitrogen), 0.5 µl of 10 mM dNTPs (Invitrogen), 0.5 µM of each 
primer and 0.15 µM of probe, 0.5 µl ROX reference dye (Invitrogen), and 
0.1 µl Platinum Taq (Invitrogen). To quantify the number of cells in each re-
action, qPCR for albumin gene was performed in the same plate using the 
same PCR conditions. Previously published primer-probe combinations 
were used for both albumin and HIV-gag amplification (Douek et al., 2002). 
Two standard curves were included in each run: the first ranging from 3 to 
3 × 106 copies of a plasmid containing the full-length HIV-1 genome and the 
second ranging from 20 to 2 × 106 copies of a plasmid containing albumin 
amplicon. Extraction and quantification were validated on 10-fold dilutions 
of Ach2 cells diluted into an equivalent number of uninfected cells (5 × 104 
total cells). HIV-DNA load was expressed as number of copies per 106 cells.
Statistical analyses. Statistical significance (p-values) was obtained using 
one-way ANOVA (Kruskal-Wallis test), followed by Student’s t test for 
multiple comparisons or a Spearman rank test for correlations. Statistical 
analyses of global cytokine profiles (pie charts) were performed by partial 
permutation tests using the SPICE software as previously described (Roederer 
et al., 2011).
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Flow cytometry. Data were acquired on LSR SORP four lasers (405, 488, 
532, and 633 nm), analyzed using FlowJo (v9.4.11; Tree Star) and SPICE 
(v5.21; developed by M. Roederer, National Institutes of Health; Roederer 
et al., 2011). At least 100,000 events were acquired for each sample.
Intracellular cytokine staining. Cryopreserved lymph node mononuclear 
cells were thawed and resuspended in complete RPMI medium (Gibco; Life 
Technologies; 10% heat-inactivated FBS [Institut de Biotechnologies Jacques 
Boy], 100 IU/ml penicillin, and 100 µg/ml streptomycin [BioConcept]) 
at 106 cells/ml and stimulated with 100 ng/ml PMA (Sigma-Aldrich) and 
1 µg/ml ionomycin (Sigma-Aldrich) in the presence of Brefeldin A (BD) for 
6 h at 37°C or with 1 µg/ml of broad spectrum subtype B HIV-1 PTE pep-
tide pools encompassing Gag, Pol, and Env proteins (Comprehensive T Cell 
Vaccine Immune Monitoring Consortium) in the presence of Brefeldin A 
(BD) for 18 h at 37°C (Li et al., 2006). Dead cells were excluded using the 
Aqua LIVE/DEAD stain kit at 4°C for 25 min (Life Technologies). Cells 
were stained at 4°C for 25 min with anti-CD3 APC-H7, anti-CD4 ECD, 
or PE-CF594, anti-CD8 EFluor 625NC, anti-CXCR5 Alexa Fluor 488, 
and anti-PD-1 PeCy7, permeabilized for 20 min at 20°C with Cytofix/
Cytoperm (BD), washed and stained at 4°C for 25 min with anti–IL-2 
PerCP-Cy5.5, anti-TNF APC, anti–IFN- Alexa Fluor 700, and anti–IL-21 
PE. Frequencies of cytokine-producing CD4 T cell population were assessed 
by flow cytometry.
Ki-67 and Bcl-6 expression. Lymph node mononuclear cells were thawed 
and dead cells were excluded using the aqua LIVE/DEAD stain kit at 4°C for 
25 min. Cells were stained with anti-CD3 APC-H7, anti-CD8 PerCp-Cy5.5, 
anti-CD4 PB, anti-CD45RA PeCy5, anti-CXCR5 APC, and anti–PD-1 
PeCy7 at 4°C for 25 min, and then permeabilized for 1 h at 4°C with Foxp3 
Fixation/Permeabilization kit (eBioscience), washed, and stained with anti–
Ki-67 PE and anti–Bcl-6 Alexa Fluor 488 at 4°C for 25 min. Expression 
of Ki-67 on CXCR5PD-1, CXCR5PD-1+, CXCR5+PD-1, and 
CXCR5+PD-1+ CD4 T cell populations was assessed by flow cytometry.
Sorting of CD4 T cell populations. Cryopreserved lymph node mono-
nuclear cells were thawed and stained with the violet LIVE/DEAD stain kit 
(4°C; 15 min) and then with anti-CD3 APC-H7, anti-CD4 APC, anti-
CD45RA ECD, anti-CXCR5 PE, and anti–PD-1 PeCy7 at 4°C for 25 min, 
and the CXCR5PD-1, CXCR5PD-1+, CXCR5+PD-1, and CXCR5+ 
PD-1+ CD4 T cell populations were sorted using a FACSAria (BD). In 
all sorting experiments, the grade of purity of the sorted cell populations 
was >97%.
B cell/T cell co-culture assay. B cells from lymph node mononuclear 
cells were enriched using CD19-positive selection (STEMCELL Technolo-
gies), and dead cells were excluded using the violet LIVE/DEAD stain kit at 
4°C for 15 min and stained at 4°C for 25 min with the anti-CD19 APC– 
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